These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8938552)

  • 1. Increased biliary secretion of cysteinyl-leukotrienes in human bile duct obstruction.
    Richter L; Hesselbarth N; Eitner K; Schubert K; Bosseckert H; Krell H
    J Hepatol; 1996 Nov; 25(5):725-32. PubMed ID: 8938552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cysteinyl leukotrienes in the bile of patients with obstructive jaundice.
    Uemura M; Kojima H; Buchholz U; Kikuchi E; Matsumoto M; Kikukawa M; Imazu H; Fukui H; Tsujii T; Keppler D
    J Gastroenterol; 2002; 37(10):821-30. PubMed ID: 12424566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukotriene C4 metabolism by hepatoma cells and liver.
    Keppler D; Huber M; Weckbecker G; Hagmann W; Denzlinger C; Guhlmann A
    Adv Enzyme Regul; 1987; 26():211-24. PubMed ID: 2890280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of cysteinyl leukotrienes in monkey and man.
    Huber M; Müller J; Leier I; Jedlitschky G; Ball HA; Moore KP; Taylor GW; Williams R; Keppler D
    Eur J Biochem; 1990 Nov; 194(1):309-15. PubMed ID: 2174780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cysteinyl leukotrienes in the urine of patients with liver diseases.
    Uemura M; Buchholz U; Kojima H; Keppler A; Hafkemeyer P; Fukui H; Tsujii T; Keppler D
    Hepatology; 1994 Oct; 20(4 Pt 1):804-12. PubMed ID: 7927219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of sinusoidal uptake and biliary excretion of cysteinyl leukotrienes in perfused rat liver.
    Wettstein M; Gerok W; Häussinger D
    Eur J Biochem; 1990 Jul; 191(1):251-5. PubMed ID: 2165907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the leukotriene receptor antagonists FPL 55712, LY 163443, and MK-571 on the elimination of cysteinyl leukotrienes in the rat.
    Denzlinger C; Grimberg M; Kapp A; Haberl C; Wilmanns W
    Br J Pharmacol; 1991 Apr; 102(4):865-70. PubMed ID: 1855116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of cysteinyl leukotrienes in non-recirculating rat liver perfusion. Hepatocyte heterogeneity in uptake and biliary excretion.
    Wettstein M; Gerok W; Häussinger D
    Eur J Biochem; 1989 Apr; 181(1):115-24. PubMed ID: 2565811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholestasis: pathophysiology and pathobiochemistry.
    Krell H; Enderle GJ
    Z Gastroenterol; 1993 Feb; 31 Suppl 2():11-5. PubMed ID: 7483688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia and CCl4-induced liver injury, but not acidosis, impair metabolism of cysteinyl leukotrienes in perfused rat liver.
    Wettstein M; Gerok W; Häussinger D
    Hepatology; 1990 May; 11(5):866-73. PubMed ID: 2161395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased excretion of endogenous urinary leukotriene E4 in extrahepatic cholestasis.
    Mayatepek E; Pecher G
    Clin Chim Acta; 1993 Sep; 218(2):185-92. PubMed ID: 8306442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bile acid excretion during drainage of extrahepatic cholestasis with refeeding of bile.
    Hedenborg G; Norlander A; Norman A
    Scand J Clin Lab Invest; 1982 Nov; 42(7):551-6. PubMed ID: 7156866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biliary indocyanine green excretion as a predictor of hepatic adenosine triphosphate levels in patients with obstructive jaundice.
    Chijiiwa K; Watanabe M; Nakano K; Noshiro H; Tanaka M
    Am J Surg; 2000 Feb; 179(2):161-6. PubMed ID: 10773154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different pathomechanisms of altered biliary leukotriene C4 elimination in isolated perfused rat livers.
    Enderle GJ; Delabar U; Krell H
    Biochem Pharmacol; 1995 Jan; 49(3):297-304. PubMed ID: 7857316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similarities and differences between models of extrahepatic biliary obstruction and complete biliary retention without obstruction in the rat.
    Hardison WG; Weiner RG; Hatoff DE; Miyai K
    Hepatology; 1983; 3(3):383-90. PubMed ID: 6840684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The biliary excretion of sulphated and non-sulphated bile acids and bilirubin in patients with external bile drainage.
    Dooley JS; Bartholomew C; Summerfield JA; Billing BH
    Clin Sci (Lond); 1984 Jul; 67(1):61-8. PubMed ID: 6734078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of hepatocytes function following decompression therapy in extrahepatic biliary obstructed patients: metabolite profiling of bile by NMR.
    Bala L; Tripathi P; Choudhuri G; Khetrapal CL
    J Pharm Biomed Anal; 2011 Aug; 56(1):54-63. PubMed ID: 21621940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of cysteinyl leukotrienes and their metabolites in bile of patients with peroxisomal or mitochondrial beta-oxidation defects.
    Mayatepek E; Ferdinandusse S; Meissner T; Wanders RJ
    Clin Chim Acta; 2004 Jul; 345(1-2):89-92. PubMed ID: 15193981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bile acid synthesis and excretion following release of total extrahepatic cholestasis by percutaneous transhepatic drainage.
    Eklund A; Norlander A; Norman A
    Eur J Clin Invest; 1980 Oct; 10(5):349-55. PubMed ID: 6777167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic inactivation of leukotrienes.
    Keppler D; Huber M; Baumert T; Guhlmann A
    Adv Enzyme Regul; 1989; 28():307-19. PubMed ID: 2624175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.